BrightSpring Health Services (NASDAQ:BTSG) Shares Gap Up on Earnings Beat

BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report)’s stock price gapped up prior to trading on Friday following a stronger than expected earnings report. The stock had previously closed at $60.22, but opened at $65.29. BrightSpring Health Services shares last traded at $67.4820, with a volume of 721,034 shares trading hands.

The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. The company had revenue of $4.21 billion for the quarter, compared to analyst estimates of $3.88 billion. The business’s quarterly revenue was up 26.4% compared to the same quarter last year.

Key BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

  • Positive Sentiment: Revenue significantly surpassed estimates: Third-quarter revenue increased 26.4% year over year to $4.21 billion, above analysts’ $3.88 billion forecast. The growth reflects continued demand for BrightSpring’s home- and community-based healthcare services. BrightSpring Q3 revenue skyrockets 26% to $4.21 billion
  • Positive Sentiment: Earnings beat expectations: BrightSpring reported quarterly EPS of $0.54, up from $0.30 a year earlier and ahead of consensus estimates ranging from $0.47 to $0.49. The result extends the company’s run of consecutive EPS surprises, reinforcing confidence in its execution. BTSG Q3 Earnings and Revenues Surpass Estimates
  • Positive Sentiment: Full-year guidance was increased: Management raised its 2026 revenue and Adjusted EBITDA guidance, signaling confidence that operating momentum will continue beyond the strong quarter. BrightSpring Reports Q3 Results and Increases Full-Year Guidance
  • Neutral Sentiment: BrightSpring posted a 16.73% return on equity and a 2.55% net margin. While profitability improved, the relatively narrow net margin and a debt-to-equity ratio of 1.06 remain factors investors may monitor as the company expands. BrightSpring Bottom Line Rises in Q3
  • Negative Sentiment: Before the release, analysts highlighted potential risks from the Inflation Reduction Act and questioned whether growth could offset regulatory and reimbursement pressures. The strong results and raised outlook currently appear to have outweighed those concerns, but they remain longer-term risks. BTSG Ahead of Q3 Earnings

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on BTSG. Guggenheim assumed coverage on BrightSpring Health Services in a research report on Monday, July 13th. They set a “buy” rating and a $81.00 target price on the stock. Zacks Research lowered BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 2nd. Wall Street Zen downgraded BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $70.00 target price on shares of BrightSpring Health Services in a research report on Monday, August 3rd. Finally, Weiss Ratings cut BrightSpring Health Services from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, BrightSpring Health Services has an average rating of “Moderate Buy” and a consensus price target of $72.88.

Read Our Latest Report on BTSG

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company bought a new position in BrightSpring Health Services during the 2nd quarter worth $239,377,000. Bank of America Corp DE acquired a new position in BrightSpring Health Services during the 2nd quarter valued at about $127,475,000. Bank of New York Mellon Corp bought a new position in BrightSpring Health Services in the 2nd quarter worth about $118,162,000. Arrowstreet Capital Limited Partnership grew its position in BrightSpring Health Services by 109.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,370,440 shares of the company’s stock worth $58,394,000 after purchasing an additional 716,949 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in BrightSpring Health Services by 236.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 860,134 shares of the company’s stock worth $36,151,000 after purchasing an additional 604,232 shares during the last quarter.

BrightSpring Health Services Stock Up 10.1%

The firm’s 50 day simple moving average is $59.79 and its 200 day simple moving average is $54.40. The company has a market cap of $13.12 billion, a price-to-earnings ratio of 39.94, a price-to-earnings-growth ratio of 0.77 and a beta of 1.87. The company has a quick ratio of 1.22, a current ratio of 1.59 and a debt-to-equity ratio of 1.06.

BrightSpring Health Services Company Profile

(Get Free Report)

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.

Read More

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.